Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Viasat
VSAT
$11.4B
| $6.76M | ﹤0.01% |
196,042
+30,008
| +18% | +$1.06M |
|
1977
Denali Therapeutics
DNLI
$3.97B
| $6.73M | ﹤0.01% |
407,359
-29,642
| -7% | -$500K |
|
1978
RH
RH
$3.4B
| $6.71M | ﹤0.01% |
37,477
-108,770
| -74% | -$18.6M |
|
|
SFBS
1979
ServisFirst Bancshares
SFBS
$5B
| $6.71M | ﹤0.01% |
93,512
+12,398
| +15% | +$910K |
|
1980
CALL
Shopify
SHOP
$204B
| $6.71M | ﹤0.01% |
41,700
-20,300
| -33% | -$3.26M |
|
1981
CALL
FedEx
FDX
$80.3B
| $6.7M | ﹤0.01% |
23,200
| – | – |
|
|
AERO
1982
Grupo Aeromexico SAB de CV
AERO
$2.31B
| $6.7M | ﹤0.01% |
+305,000
| New | +$5.84M |
|
|
PCH
1983
DELISTED
PotlatchDeltic
PCH
| $6.69M | ﹤0.01% |
168,276
-10,070
| -6% | -$408K |
|
1984
Descartes Systems
DSGX
$6.62B
| $6.69M | ﹤0.01% |
76,338
+71,308
| +1,418% | +$6.37M |
|
1985
VSE Corp
VSEC
$6.48B
| $6.69M | ﹤0.01% |
38,707
+5,193
| +15% | +$888K |
|
1986
Autoliv
ALV
$8.89B
| $6.68M | ﹤0.01% |
56,286
-5,409
| -9% | -$646K |
|
1987
Eastman Chemical
EMN
$8.43B
| $6.68M | ﹤0.01% |
104,639
-380,282
| -78% | -$23.4M |
|
1988
Equinox Gold
EQX
$13.1B
| $6.67M | ﹤0.01% |
475,356
+239,452
| +102% | +$3.02M |
|
1989
Genesis Energy
GEL
$1.92B
| $6.65M | ﹤0.01% |
426,198
+90,761
| +27% | +$1.42M |
|
1990
PUT
Yeti Holdings
YETI
$3.44B
| $6.63M | ﹤0.01% |
+150,000
| New | +$5.77M |
|
1991
NextNav
NN
$3.29B
| $6.62M | ﹤0.01% |
398,051
+222,027
| +126% | +$3.15M |
|
1992
WesBanco
WSBC
$4.1B
| $6.62M | ﹤0.01% |
199,064
+35,498
| +22% | +$1.15M |
|
1993
IAMGOLD
IAG
$10.1B
| $6.62M | ﹤0.01% |
401,178
-258,792
| -39% | -$3.65M |
|
1994
Tarsus Pharmaceuticals
TARS
$3.02B
| $6.61M | ﹤0.01% |
80,784
-11,342
| -12% | -$847K |
|
1995
Syndax Pharmaceuticals
SNDX
$1.7B
| $6.61M | ﹤0.01% |
314,672
-33,389
| -10% | -$582K |
|
1996
Albemarle Corp Depositary Shares
ALB.PRA
$2.51B
| $6.6M | ﹤0.01% |
111,065
| – | – |
|
1997
Itron
ITRI
$4.5B
| $6.58M | ﹤0.01% |
70,882
+6,094
| +9% | +$664K |
|
1998
James Hardie Industries
JHX
$17.9B
| $6.57M | ﹤0.01% |
316,731
+284,068
| +870% | +$5.7M |
|
1999
American States Water
AWR
$3.52B
| $6.56M | ﹤0.01% |
90,517
+11,810
| +15% | +$869K |
|
2000
Allison Transmission
ALSN
$10.2B
| $6.56M | ﹤0.01% |
66,967
-90,826
| -58% | -$7.96M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.